Qlarant Inc.
Easton, MD Doing business as Quality Health
- UEI
- N26KL9SR4Q77
- CAGE
- 7EEC3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Corporate family
-
-
- Qlarant Quality Solutions, Inc. · Easton, MD Z9EFQTHVYNT7
- Qlarant Advisory Solutions, Inc. YGRUYBLGUUM5
- Qlarant Integrity Solutions LLC · Easton, MD DU1AQ7UHLLT3
-
- SAM.gov registration date
- Physical address
- 28464 Marlboro Ave, Easton, MD 21601, USA
- Website
- qlarant.com
- Founded
- 1973
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Consulting
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Purchase of data analysis service. | Drug Enforcement Administration | $5,410 |
Similar vendors
About the company
Qlarant Inc., doing business as Quality Health, is a non-profit organization registered to receive federal government awards since June 15, 2015. The company specializes in providing professional, scientific, and technical services to federal agencies, particularly in the healthcare sector. Qlarant Inc. operates as a parent company and has at least one subsidiary, Qlarant Integrity Solutions LLC, which is involved in federal contracting. The organization's expertise appears to be focused on data analysis, program integrity, and fraud detection within government healthcare programs.
Qlarant Inc., through its subsidiary Qlarant Integrity Solutions LLC, has been awarded a significant federal contract by the Centers for Medicare and Medicaid Services (CMS). This contract, valued at $34,219,940.00, is a cost-plus-fixed-fee agreement for conducting proactive data analysis on Medicare Parts C and D. The contract, known as the Plan Program Integrity Medicare Drug Integrity Contract (PPI MEDIC), is set to run through June 2025. The primary objective of this work is to identify program vulnerabilities related to drug trends, outlier prescribers, and high-risk pharmacies to detect fraud within the Medicare system. This contract was awarded through a competitive solicitation process without any set-aside designation, under the NAICS code 541990 for All Other Professional, Scientific, and Technical Services.
Based on the available information, there are no specific details regarding federal grant awards to Qlarant Inc. or its subsidiaries. The company's involvement in federal funding appears to be primarily through contract awards, particularly in the healthcare sector. The absence of grant award information suggests that Qlarant Inc.'s primary mode of engagement with the federal government is through contractual services rather than grant-funded projects. However, it's important to note that this conclusion is based on the limited data provided and may not represent the full scope of Qlarant Inc.'s involvement in federal funding programs.
Quick answers
Is Qlarant Inc. registered in SAM.gov?
Yes. Qlarant Inc.'s SAM.gov registration is active through March 12, 2027.
What is Qlarant Inc.'s most recent federal award?
Qlarant Inc.'s most recent federal contract award is Purchase of data analysis service (15DDNY19P00000011), from Drug Enforcement Administration, on November 8, 2018.
On GovTribe
See Qlarant Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors